From: Three allele combinations associated with Multiple Sclerosis
Allelic combinations | MS patients, N (%) | Controls, N (%) | p-value# | OR (95% CI)## |
---|---|---|---|---|
-509TGFβ1*C, DRB1*18(3), CTLA4*G (trio 1)* | 5 (5.3) | 0 (0) | 0.0086 | 18.0 (1.0–330) |
-509TGFβ1*C, DRB1*18(3) | 5 (4.4) | 2 (0.7) | 0.029 |  |
-509TGFβ1*C, CTLA4*G | 63 (61) | 102 (58) | 0.61 |  |
DRB1*18(3), CTLA4*G | 5 (3.0) | 2 (1.1) | 0.26 | Â |
-238TNF*B1,-308TNF*A2, CTLA4*G (trio 2)** | 11 (8.7) | 0 (0) | 0.0033 | 17.4 (1.1–300) |
-238TNF*B1,-308TNF*A2 | 13 (9.9) | 6 (5.4) | 0.26 | Â |
-238TNF*B1, CTLA4*G | 38 (30) | 15 (17) | 0.036 | Â |
-308TNF*A2, CTLA4*G | 26 (16) | 15 (14) | 0.73 | Â |